BRANDI PLUMMER: Open Payments
NPI 1023697265 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 76 payments from 18 companies in 2025. Trend: 2023 $746 · 2024 $1,813 · 2025 $1,293
Food & beverage: $1,293
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $204 |
| Novo Nordisk Inc | 12 | $203 |
| ABBVIE INC. | 7 | $174 |
| Dexcom, Inc. | 9 | $166 |
| PFIZER INC. | 11 | $144 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Amgen Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $43 |
| Exact Sciences Corporation | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: LEQVIO, Dexcom G6 Transmitter, VRAYLAR, NURTEC ODT, Ozempic, Wegovy, Auvelity, JARDIANCE.
Industry payments across FL — which companies pay providers there.
